Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

RTI Surgical Inc Lowers FY 2013 Guidance; Issues Q4 2013 Guidance Below Analysts' Estimates


Tuesday, 29 Oct 2013 08:00am EDT 

RTI Surgical Inc announced that based on the acquisition of Pioneer and results from the first three quarters the company is revising its fiscal revenue guidance for 2013. The Company now expects fiscal revenue guidance for 2013 to be between $196 million to $197 million, as compared to prior guidance of $211 million to $215 million. Fiscal 2013 net loss per fully diluted common share is expected to be approximately $0.28, based on 56.4 million fully diluted shares outstanding, as compared to prior guidance of full year net loss per fully diluted common share of $0.13 to $0.11. For the fourth quarter of 2013, the Company expects revenues to be between $59 million and $60 million and net loss per fully diluted common share (EPS) to be approximately $0.09, based on 56.4 million fully diluted shares outstanding. Excluding certain acquisition related expenses and certain purchase accounting adjustments, fourth quarter net loss per fully diluted common share is expected to be approximately $0.01. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $203 million and EPS of $0.05 for fiscal 2013; and revenue of $68 million and EPS of $0.03 for the fourth quarter of 2013. 

Company Quote

5.48
0.17 +3.20%
19 Dec 2014